RECOMBINANT MONOCLONAL ANTIBODIES

Brand (click to sort) Owner Address Description
YVLING LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES 3 avenue des TropiquesFR
France
Recombinant monoclonal antibodies directed against the ...
DABNOLIA LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES 3 avenue des TropiquesFR
France
Recombinant monoclonal antibodies directed against the ...
RHOVLING LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES 3 avenue des TropiquesFR
France
Recombinant monoclonal antibodies directed against the ...
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to the vitronectin ?v?3 receptor and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of ?v?3-mediated disorders, such as restenosis, in human patients.